Top BRD4 inhibition by ABBV-744 in cancer research studies Secrets
Participant consumed grapefruit or grapefruit merchandise within 3 days ahead of the 1st dose of study drug.- "Our study uncovered the vital position on the KLF16/MYC regulatory axis in modulating tumor development and chemotherapy sensitivity in BLCA, suggesting that combining bromodomain inhibitors, like OTX015 or ABBV-744, with DDP or gemcitabin